Improved protection against cervical cancer
Not all hrHPV genotypes carry an equal risk!
Focus on the infection that matters:
mRNA HPV 16, 18, 31, 33, 45, 52, 58
Only a few HPV genotypes are highly associated with cervical cancer and require the most aggressive management, whereas others carry a lower risk of disease.
Knowledge of the HPV mRNA genotype status greatly assists in the clinical decision-making of a patient’s risk of having disease now or in the near future and to choose the next appropriate management step:
Read about PreTect, our mission and why our technology is important in the fight against cervical cancer
At PreTect, we have developed a test specifically designed for women in their twenties who are at risk of having early signs of cancer missed. We have developed our test to be used in collaboration with cytology to ensure higher safety for women…
“We are truly impressed by the HPV mRNA Service testing; delivering results of great importance for risk stratification of our patients. The fast turnaround time exceeded our expectations as work was done faster than we thought was possible. Everyone was very helpful, professional and thorough. All of these made us feel like our business was their first priority. I have no hesitation in highly recommending their excellent service! ”